162 related articles for article (PubMed ID: 8104445)
1. Correlation between [3H]thymidine and proliferating cell nuclear antigen (PCNA)/cyclin indices in archival, formaldehyde-fixed human colorectal tissues.
Bleiberg H; Morret M; Galand P
Eur J Cancer; 1993; 29A(3):400-3. PubMed ID: 8104445
[TBL] [Abstract][Full Text] [Related]
2. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues.
Galand P; Degraef C
Cell Tissue Kinet; 1989 Sep; 22(5):383-92. PubMed ID: 2575456
[TBL] [Abstract][Full Text] [Related]
3. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
[TBL] [Abstract][Full Text] [Related]
4. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
[TBL] [Abstract][Full Text] [Related]
5. Changes of colon epithelium proliferation due to individual aging with cyclin proliferating cell nuclear antigen (PCNA/cyclin) immunostaining compared to [3H]-thymidine radioautography.
Morita T; Usuda N; Hanai T; Nagata T
Histochemistry; 1994 Jan; 101(1):13-20. PubMed ID: 7913088
[TBL] [Abstract][Full Text] [Related]
6. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
[TBL] [Abstract][Full Text] [Related]
7. Retrospective assessment of liver cell proliferation via PCNA: a comparison with tritiated thymidine.
Dietrich DR; Candrian R; Marsman DS; Popp JA; Kaufmann WK; Swenberg JA
Cancer Lett; 1994 Apr; 79(1):45-51. PubMed ID: 7910515
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of S-phase cells in normal human and rat liver by PC10 monoclonal antibody.
Mancini R; Marucci L; Benedetti A; Jezequel AM; Orlandi F
Liver; 1994 Apr; 14(2):57-64. PubMed ID: 7910934
[TBL] [Abstract][Full Text] [Related]
9. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Methodological aspects and application to routine diagnostic material.
Diebold J; Lai MD; Löhrs U
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):283-9. PubMed ID: 1359701
[TBL] [Abstract][Full Text] [Related]
10. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
Gelb AB; Kamel OW; LeBrun DP; Warnke RA
Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
[TBL] [Abstract][Full Text] [Related]
11. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies.
Shimizu T; Usuda N; Yamanda T; Sugenoya A; Iida F
Cancer; 1993 May; 71(9):2807-12. PubMed ID: 8096795
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity assessed by anti-PCNA and Ki67 monoclonal antibodies in canine testicular tumours.
Sarli G; Benazzi C; Preziosi R; Marcato PS
J Comp Pathol; 1994 May; 110(4):357-68. PubMed ID: 7914524
[TBL] [Abstract][Full Text] [Related]
13. Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats.
Foley J; Ton T; Maronpot R; Butterworth B; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):199-205. PubMed ID: 7912186
[TBL] [Abstract][Full Text] [Related]
14. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
15. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen expression in central nervous system neoplasms.
Allegranza A; Girlando S; Arrigoni GL; Veronese S; Mauri FA; Gambacorta M; Pollo B; Dalla Palma P; Barbareschi M
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):417-23. PubMed ID: 1721471
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen expression in normal, preneoplastic, and neoplastic colonic epithelium of the rat.
Yamada K; Yoshitake K; Sato M; Ahnen DJ
Gastroenterology; 1992 Jul; 103(1):160-7. PubMed ID: 1351857
[TBL] [Abstract][Full Text] [Related]
18. Assessment of proliferating-cell nuclear antigen immunostaining in soft-tissue tumours: relationship to histological grade and mitotic activity.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Tsenga A; Thomas-Tsagli E
J Cancer Res Clin Oncol; 1994; 120(7):393-8. PubMed ID: 7910610
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity of gastric cancer assessed by immunostaining for proliferating cell nuclear antigen.
Inada T; Imura J; Ichikawa A; Ogata Y; Shimamura K
J Surg Oncol; 1993 Nov; 54(3):146-51; discussion 151-2. PubMed ID: 8105151
[TBL] [Abstract][Full Text] [Related]
20. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
